Home › Research › Getting a diagnosis
Drug treatments in Alzheimer's disease
Briggs R, Kennelly SP, O'Neill D.. Clinical medicine (London, England), 2016-06-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease (AD) and these act to control symptoms rather than alter the course of the disease. Studies of potential disease-modifying therapy have generally been undertaken in patients with clinically detectable disease, yet evidence suggests that the pathological changes associated with AD begin several years before this. It is possible that pharmacological therapy may be beneficial in this pre-clinical stage before the neurodegenerative process is established. Techniques providing earlier diagnosis, such as cerebrospinal fluid biomarkers and amyloid positron emission tomography neuroimaging, are key to testing this theory in clinical trials. Recent results from trials of agents such as aducanumab are encouraging but must also be interpreted with caution. Such medicines could potentially delay the onset of dementia and would therefore markedly reduce its prevalence. However, we currently remain a good distance away from clinically available disease-modifying therapy.
What this study adds
Evidence grade: Low
This is a narrative review. This review states that only five treatments are approved for Alzheimer's disease and that these control symptoms rather than change the course of the disease. It notes that disease-modifying therapy is not yet clinically available, though early results from some trials are described as encouraging but requiring caution.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Briggs, R., Kennelly, S. P., & O'Neill, D. (2016). Drug treatments in Alzheimer's disease. Clinical medicine (London, England). https://doi.org/10.7861/clinmedicine.16-3-247
Vancouver
Briggs R, Kennelly SP, O'Neill D. Drug treatments in Alzheimer's disease. Clinical medicine (London, England). 2016. doi:10.7861/clinmedicine.16-3-247. PMID: 27251914.
BibTeX
@article{briggs2016-27251914,
author = {Briggs, R. and Kennelly, S. P. and O'Neill, D.},
title = {{Drug treatments in Alzheimer's disease}},
journal = {Clinical medicine (London, England)},
year = {2016},
doi = {10.7861/clinmedicine.16-3-247},
pmid = {27251914},
url = {https://doi.org/10.7861/clinmedicine.16-3-247}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Despite the significant public health issue that it poses, only five medical treatments have been approved for Alzheimer's disease (AD) and these act to control symptoms rather than alter the course of the disease.
- Studies of potential disease-modifying therapy have generally been undertaken in patients with clinically detectable disease, yet evidence suggests that the pathological changes associated with AD begin several years before this.
- Recent results from trials of agents such as aducanumab are encouraging but must also be interpreted with caution.
Why it matters
This review states that only five treatments are approved for Alzheimer's disease and that these control symptoms rather than change the course of the disease. It notes that disease-modifying therapy is not yet clinically available, though early results from some trials are described as encouraging but requiring caution.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Evidence strengthLow
How this study scored 43/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Clinical medicine (London, England)) |
| Journal's citation record | 1 / 4 | Clinical Medicine: journal h-index 116 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 2016 — within 20 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 6 / 7 | Cited 568 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 47.3 citations a year over 12 year(s) since 2016 |
| Impact for its field and year | 3 / 6 | Cited 7.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 5 other studies in this library |
| Still being cited | 3 / 4 | Cited 198 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Desmond J O’Neill: h-index 52 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Tallaght University Hospital: institution h-index 199 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 27251914) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.7861/clinmedicine.16-3-247
- PubMed: 27251914
- Original source →
- Free full text: Clinical Medicine →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 23.
Later studies that cite this one
5 studies in the alzhub library list this one in their references.
Related studies in Getting a diagnosis from nearby years
Also in Getting a diagnosis
141 studies in the library are filed under Getting a diagnosis with no topic tag they share with another; these are this study's neighbours in a fixed tour of them. The Getting a diagnosis hub.